FFL Flash Alerts - The Jaguars WR gets a tough test at home today - can he find success against the Steelers?
FFL Flash Alerts - The Jaguars WR gets a tough test at home today - can he find success against the Steelers?
President Donald Trump partook in an annual holiday tradition – the pardoning of the National Thanksgiving Turkey, a gobbler named Corn.
U.S. stocks rallied on Tuesday and the Dow breached the 30,000 level for the first time, as investors anticipated a 2021 economic recovery on coronavirus vaccine progress and the formal clearance for President-elect Joe Biden's transition to the White House. Of the 11 major S&P sectors, 10 gained ground, led by economically sensitive stocks such as financials, materials and energy, while industrials hit a record. President Donald Trump finally gave the green light for the formal transfer of power to begin on Monday, a process that was delayed for weeks despite Democrat Joe Biden emerging as the clear winner in the U.S. elections.
Save up to 75% on must-have home and kitchen essentials, including bakeware, smart home tech, furniture, and more.
A photo purports to show preparations for Joe Biden's inauguration. But, it's actually from Bill Clinton's inauguration in 1993.
Five specific sleep habits are associated with a lower risk of heart failure, say medical experts.
Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare and other high-burden diseases, today announced updated timing for its Fireside Chat presentation at an upcoming investor conference hosted by Evercore.
The Princess Grace Foundation-USA Unveils Paul Tazewell-Designed Face Masks Inspired By Grace Kelly's Iconic Fashion Looks For The HolidaysPR NewswireNEW YORK, Nov. 24, 2020 /PRNewswire/ -- The Princess Grace Foundation-USA today unveiled an exclusive line of limited-edition, hand-sewn face masks inspired by Grace Kelly's iconic fashion looks for the holiday season to help support the creative community.
CLEVELAND, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) today announced the closing of its initial public offering (“IPO”) of 53,590,000 shares of its common stock at a public offering price of $23.00 per share, for gross proceeds of approximately $1.2 billion, before deducting underwriting discounts and commissions and offering expenses. J.P. Morgan, Credit Suisse, Goldman Sachs & Co. LLC and Jefferies acted as joint lead book-running managers and as representatives of the underwriters for the offering. Barclays, Citigroup and RBC Capital Markets acted as joint book-running managers for the offering. BNP PARIBAS, KeyBanc Capital Markets, Citizens Capital Markets, ING, Academy Securities, Loop Capital Markets, Penserra Securities LLC, Siebert Williams Shank and Tigress Financial Partners acted as co-managers for the offering.The offering was made only by means of a prospectus. Copies of the final prospectus relating to the offering may be obtained from: J.P. Morgan Securities, LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-866-803-9204 or by email at email@example.com; Credit Suisse Securities (USA), LLC, Attention: Prospectus Department, 6933 Louis Stephens Drive, Morrisville, NC 27560, by telephone at (800) 221-1037, or by email at firstname.lastname@example.org; Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone 1-866- 471-2526 or by email at Prospectusemail@example.com; or Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, by telephone 1-877-821-7388 or by email at Prospectus_Department@Jefferies.com.A registration statement relating to these securities was declared effective as of November 19, 2020 by the Securities and Exchange Commission.This press release shall not constitute an offer to sell, or the solicitation of an offer to buy these securities, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.Forward-looking Statement:Statements in this press release regarding the Company that are not historical facts are “forward-looking statements” that involve risks and uncertainties. Certain of these risks and uncertainties are described in the Company's registration statement on Form S-1 filed with the SEC, including under the headings of "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in the registration statement. Forward-looking statements made in this release speak only as of the date of this release, and the Company undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances, except as required by law.About Sotera Health:Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.CONTACTS: Sally J. Curley, IRCJenny Kobin Curley Global IR, LLCIR Advisory Solutions IR@soterahealth.com IR@soterahealth.com Kristin Gibbs Chief Marketing Officer, Sotera Health firstname.lastname@example.org Source: Sotera Health Company
EVO Payments Announces Proposed Offering of Common Stock
Chinese ride-sharing company Didi began rolling out a service in Mexico this week to let female drivers select only other women as their passengers, a move aimed at encouraging their safety as the country confronts worsening gender violence. Called "Didi Mujer," or Didi Woman, the program is being piloted in Mexico City, Guadalajara, Monterrey and Tijuana, and Didi hopes if more women join the platform, passengers eventually will be able to exclusively choose female drivers. Didi's rival, Uber Technologies Inc, earlier this month also launched an option for female drivers in Mexico to select only women passengers, in line with a similar Uber program in Saudi Arabia.
Ottawa and Québec invest close to $15 M to offer a more reliable and accessible network in the Nord-du-Québec regionCanada NewsWireCHIBOUGAMEAU, QC, Nov. 24, 2020 /CNW/ - Quebecers know that high-speed Internet access is no longer a luxury; it is essential for everyone, including those living in rural and remote regions.
The benchmark 10-year yield, which hit a session high of 0.888%, was last up 2.4 basis points at 0.8832% and the yield curve steepened. The yield on 30-year bonds was last up 4.4 basis points at 1.6072%. "With yields of 85 or 88 basis points, that's not very attractive on the 10-year (note), and (people are) going to look for returns elsewhere," he said.
US President Donald Trump visits his campaign headquarters in Arlington, Virginia, November 3, 2020. – A bitterly divided America was going to the polls on Tuesday amid the worst pandemic in a century and an economic crisis to decide whether to give President Donald Trump four more years or send Democrat Joe Biden to the White House. A record-breaking number of early votes — more than 100 million — have already been cast in an election that has the nation on edge and is being closely watched in capitals around the world. (Photo by SAUL LOEB / AFP) (Photo by SAUL LOEB/AFP via Getty Images) Donald Trump’s presidency is finally coming to an end. But one important question — other than whether Trump can run again in 2024 — is whether he is allowed to pardon himself from the litany of legal investigations and civil suits he faces upon leaving office. In case you need a reminder, Trump is currently under investigation for insurance fraud, criminal tax evasion, grand larceny, and a scheme to defraud. He is also still being sued by writer E. Jean Carroll for rape. In part, many believe that Trump’s disproven claims of election fraud are just a ploy to run the clock that will eventually land him behind bars. So the question is, what kind of power does the president really have to pardon himself? According to Article II of the Constitution, a sitting president “shall have Power to grant Reprieves and Pardons for Offenses against the United States, except in Cases of Impeachment.” That may sound like we have already answered the question; however, therein lies a small yet important technicality within that phrase that requires some unpacking. The operative word? Grant. Because of this, we are actually asking the wrong question: It’s not about whether Trump can pardon himself, but whether he can grant himself a pardon. This may sound like the exact same question but bear with us. According to context clues from the text of the Constitution and the word’s meaning at the time it was written, the answer is no. He cannot pardon himself. The president only has the power to grant pardons. For context, the same word appears multiple times in various clauses of the Constitution. Every time the word appears, “grant” is a transmissive term meaning it is from one entity to another, reports The Atlantic. It is not used reflexively as in “to grant oneself” a pardon — it is always used interpersonally. Comparing a word to its uses in other instances within a historical or legal document is a common technique used by judges and legal scholars to surmise the intended meaning in context. If a court were to base its judgment solely on the context of the word in the Constitution, it would be reasonable to determine that the president cannot, in fact, grant himself a pardon. But it probably wouldn’t be that simple. One of the most common legal interpretive methods, promoted by Justice Antonin Scalia and popularized among conservatives, is to look for a term’s “original public meaning.” This would involve looking at how everyday English speakers in the late 1700s would have understood the word should they have read it in a legal document. To get an answer, one would have to look through legal dictionaries of the time. The most popular legal dictionary at the end of the 18th century was The Law-Dictionary: Explaining the Rise, Progress, and Present State of the English Law; Defining and Interpreting the Terms or Words of Art; and Comprising Copious Information on the Subjects of Law, Trade, and Government (give us a second to catch our breath). In it, the word grant has the singular definition of meaning “a deed which passes or conveys land from one man to another.” (Zoom in on “to another.”) Nowhere in that dictionary does it say that a person could grant something to themselves. Furthermore, the idea of a reflexive use of the term reportedly didn’t exist in popular language at the time. So based on context clues from the original document, legal dictionaries in use at the time, and the development of the English language in the last few centuries, the seemingly inconsequential word “grant” might have just kept us away from an even more complicated end to Trump’s presidency. Like what you see? How about some more R29 goodness, right here?Trump Once Accused A Turkey Of Refusing To ConcedeWhy Trump Supporters Refuse To Believe He Lost21 GOP Senators Privately Express Hatred For Trump
The mysterious company behind a half-million dollar contribution backing no-party candidates in three key state Senate races has attracted legal questions about its adherence to Florida law for nonprofit corporations.
Market participants continue to look past the short-term surge in Covid-19 cases and are embracing the standard reopening plays, such as retailers, airlines, and oil. The primary focus is on price action and it is a well-known fact there is a strong positive bias from the close on Tuesday to the close on Friday.
Century Communities, Inc. (NYSE: CCS), a top 10 national homebuilder, is excited to announce that it's joined Aurora's popular Harmony community. Century Communities is now selling two single-family home collections at Harmony—including 6 completely brand-new floor plans, with a versatile selection of ranch and two-story layouts featuring 3-bay garage options. Boasting over 1,300 acres with an abundance of community amenities, Harmony offers access to more than 10 miles of trails, an outdoor pool, a park, a dog park, a neighborhood P-8 school, and more. The development also has plans for a clubhouse with a fitness center and movement studio.
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome (ARDS) Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding of the Acute Respiratory Distress Syndrome (ARDS), historical and forecasted epidemiology as well as the Acute Respiratory Distress Syndrome (ARDS) market trends in the United States, EU5 (Germany, France, Italy, and United Kingdom) and Japan. The Acute Respiratory Distress Syndrome (ARDS) market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Acute Respiratory Distress Syndrome (ARDS) market size from 2017 to 2030. The report also covers current Acute Respiratory Distress Syndrome (ARDS) treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. Scope of the Report * The report covers the descriptive overview of Acute Respiratory Distress Syndrome (ARDS), explaining its causes, signs and symptoms, pathogenesis and currently available therapies. * Comprehensive insight has been provided into the Acute Respiratory Distress Syndrome (ARDS) epidemiology and treatment. * Additionally, an all-inclusive account of both the current and emerging therapies for Acute Respiratory Distress Syndrome (ARDS) are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape. * A detailed review of Acute Respiratory Distress Syndrome (ARDS) market; historical and forecasted is included in the report, covering the 7MM drug outreach. * The report provides an edge while developing business strategies, by understanding trends shaping and driving the 7MM Acute Respiratory Distress Syndrome (ARDS) market.Report Highlights * Total Incident Population of Acute Respiratory Distress Syndrome (ARDS) in the 7MM is anticipated to rise in the forecasted period (2017-2030). * The market for ARDS in the 7MM is projected to rise during the study period (2017-2030). * Dynamic research and developmental activity with 60+ companies in the pipeline at different stages. * In the coming years, Acute Respiratory Distress Syndrome (ARDS) market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market. * The companies and academics are working to assess challenges and seek opportunities that could influence Acute Respiratory Distress Syndrome (ARDS) R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition. * Major players are involved in developing therapies for Acute Respiratory Distress Syndrome (ARDS). Launch of emerging therapies will significantly impact the Acute Respiratory Distress Syndrome (ARDS) market. * The in-depth analysis of the pipeline assets across different stages of development (phase III and phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activitiesKey Topics Covered: 1 Key Insights 2 Executive Summary 3 Acute Respiratory Distress Syndrome (ARDS): Market Overview at a Glance 4 Acute Respiratory Distress Syndrome (ARDS): Disease Background and Overview 5 Case Reports 6 Epidemiology and Patient Population 7 7MM Epidemiology Analysis 8 United States Epidemiology 9 EU5 Epidemiology 10 Japan Epidemiology 11 Treatment Algorithm, Current Treatment, and Medical Practices 12 Proposed Guidelines for ARDS 13 Unmet Needs 14 Off-Label Therapies for ARDS 15 Emerging Therapies 16 Unknown Status 17 COVID-19 associated with ARDS: Emerging Drugs 18 Discontinued Products 19 Acute Respiratory Distress Syndrome (ARDS): 7MM Market Analysis 20 Attribute Analysis 21 Key Emerging Therapies: Market Forecast Assumptions 22 United States: Market Outlook 23 EU-5 Countries: Market Outlook 24 Japan Market Outlook 25 Access and Reimbursement 26 Market Drivers 27 Market Barriers 28 SWOT Analysis Companies Mentioned * Ache Laboratorios Farmaceuticos * Alexion Pharmaceuticals * Algernon Pharmaceuticals * Ampio Pharmaceuticals Inc. * Apeiron Biologics * Apeptico Forschung und Entwicklung GmbH * Aqualung Therapeutics Corp. * Athersys * aTyr Pharma * Bioaegis Therapeutics Inc. * Biohaven Pharmaceutical Holding Co. Ltd. * Biomarck Pharmaceuticals * Bioxytran Inc. * Caladrius Biosciences Inc. * Cellenkos Inc * Celularity Inc.; Sorrento Therapeutics Inc.; Lung Biotechnology PBC, a subsidiary of United Therapeutics Corp. * Cerecor Inc. * Chimerix * Cyclacel Pharmaceuticals * CytoDyn * Diffusion Pharmaceuticals Inc.; University of Virginia * Direct Biologics * Eli Lilly and Company * Faron Pharmaceuticals * GEn1E Lifesciences * GlaxoSmithKline * Histocell, S.L. * Hospital to Academy of Military Medical Sciences/Ivy Institute of Stem Cells Co. Ltd * Humanigen, Inc. * Iltoo Pharma * Implicit Bioscience * Kinevant Sciences GmbH/Roivant Sciences * Kiniksa * Kiniksa Pharmaceuticals * Laboratoire francais de Fractionnement et de Biotechnologies * Lamellar Biomedical Ltd. * Lattice Biologics Ltd. * Leading Biosciences Inc. * Mallinckrodt /Novoteris LLC * Mannkind Corp.; Immix Biopharma Inc. * Medicinova Inc. * Merck/Eli Lilly * Meridigen Biotech * Mesoblast Limited * Mylan Laboratories * Navigen pharmaceuticals * NeuroRx/Relief Therapeutics * Noveome Biotherapeutics * Noxopharm Co. * Pharmazz * PhaseBio Pharmaceuticals * Pluristem Therapeutics * Predictive Biotech, of Salt Lake City, a subsidiary of Predictive Technology Group * Quark Pharmaceuticals * Roche Pharma AG * Sage Therapeutics * Theravance Biopharma, * Tiziana * Vanda Pharmaceuticals Inc.; the University of Illinois at Chicago * Veru * Windtree Therapeutics * XORTX Therapeutics * ZyVersa TherapeuticsFor more information about this report visit https://www.researchandmarkets.com/r/vgw6l4About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Robert Streb was too young at age 33 to have look back at his only PGA Tour victory six years ago instead of looking ahead to what might be his next one. Both are part of a remarkable trend during this fall portion of the new PGA Tour season. It's a reminder that winning is never easy, and that depth of talent worldwide is not limited to the top of the ranking.
Fred VanVleet hasn't been back to Toronto since March and isn't sure when he'll be back to the city that he'll technically be calling home for at least the next four years. VanVleet - the guard who finalized his four-year, $85 million contract to remain with the Raptors on Tuesday - said he's excited for the team's looming temporary move to Tampa, Florida. Toronto will play its home games for at least the first part of this season in Tampa because of the ongoing coronavirus pandemic and how the U.S-Canada border remains closed to non-essential travel.
Be kind to your garbage disposal on Thanksgiving.